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CLETTER TO THE EDITOR
Can cardiac magnetic resonance imaging
resolve cardiac and neurological enigmas
of left ventricular
hypertrabeculation/non-compaction?
Reply
Est-ce que l’IRM peut résoudre les énigmes
cardioneurologiques d’un VG non compacté ? Réponse
We thank Drs Stöllberger and Finsterer for their comments,
and take this opportunity to respond to and clarify important
issues they have raised.
Some works suggest that current echocardiographic diag-
nostic criteria are too sensitive, resulting in over-diagnosis
of left ventricular hypertrabeculation/non-compaction
(LVNC), particularly in black individuals [1]. We agree that
it would be interesting to assess the impact of cardiac mag-
netic resonance (CMR) imaging in this population, but all 16
of the patients in our study were white.
Drs. Stöllberger and Finsterer comment on the lack of
neuromuscular disease in our patients. They have published
a report demonstrating a high prevalence of neuromuscular
disorders in the population with LVNC, and showed that this
factor was predictive of death [2]. However, as in another
series [1], this comorbidity was not detected in any of our
small population despite a systematic clinical neurological
examination and muscle enzyme serum dosage.
Six patients in our population had a family history of
LVNC; four of the patients were relatives. Among these,
we observed the same distribution of hypertrabeculacula-
tion, which predominated at the lateral and apical levels
but with different NC/C ratios. Moreover, they differed in
respect to left ventricular function, which was decreased
in the older patients. We can speculate that these patients
have the same disease, but at different stages. All of the
patients were screened for gene mutations, but we do not
have the results at this time.
Regarding the frequent complications related to LVNC,
one patient in our study had a left ventricular thrombus,
but none had a embolic event, and three received oral anti-
coagulation. Of the 16 patients, 10 were treated for heart
failure.
In our study, we observed some discrepancies between
echo and CMR for the measurement of left ventricular ejec-
tion fraction (LVEF). This was observed especially in patients
N
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doi:10.1016/j.acvd.2010.09.001and 15, in whom echo provided an overestimation. A pos-
ible explanation is the poor acoustic window in patient 15
nd very large and extensive trabeculations in patient 1,
aking the measurement of LVEF difﬁcult both by echo and
y CMR.
The differentiation between LVNC and papillary muscles,
alse tendons or aberrant bands is sometimes difﬁcult in the
hort-axis views, both by echo and CMR. In our work and in
linical practice, we tried to differentiate these structures
sing atypical echo views and several long-axis CMR slices.
In our study, we used only the maximal NC/C ratio in echo
nd CMR. We did not report the agreement between the two
echniques regarding the segment where this measurement
as made. Future studies are needed to answer to this ques-
ion. However, we recently published a report showing that
he percentage of the global trabeculated left ventricular
ass measured by magnetic resonance imaging may be a
etter parameter to evaluate the extension of LVNC [3].
There is a lack of data regarding the correlation between
he imaging and the pathological measurements. They could
elp to deﬁne stronger diagnostic criteria even if the difﬁ-
ult problem of the role of load conditions has to be taken
nto account. A pathological analysis was performed for the
eart in three transplanted patients, but we have not yet
one a comparison between echo and CMR.
Drs Stöllberger and Finsterer previously reported that
VNC may appear and disappear during a person’s lifetime
4,5]. In our opinion, this suggestion seems somewhat difﬁ-
ult to accept when we consider that LVNC is a congenital
ardiomyopathy due to the persistence of the embryonic
on-compact layer. However, as suggested by Elliot et al.
6], it is possible that normal left ventricular trabeculations
ay become more prominent in certain disease states, such
s left ventricular hypertrophy, and that, in such circum-
tances, diagnostic criteria for LVNC may be fulﬁlled despite
he absence of a unique pathology.
In conclusion, we share concerns with all of the issues
aised in this letter. The fact that such a famous medical
eam in the ﬁeld of LVNC still has questions demonstrates
he important uncertainties relating to this ‘‘fascinating’’
isease.
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